Biotech

All Articles

Acepodia, Pfizer click all together for chemistry-based tissue therapy

.Phone it a case of really good chemical make up: Acepodia, a biotech based on Nobel Champion scient...

Praxis epilepsy drug lessens seizures in stage 2 trial

.Praxis Preciseness Medicines has racked up one more midphase succeed in epilepsy this year, along w...

Three directors surrender as Dyne messages blended data for DMD applicant

.After getting away from a scientific hold several years back, Dyne Rehab has actually uncovered bra...

Arrowhead fires off stage 3 information in rare metabolic condition in front of market clash with Ionis

.Arrowhead Pharmaceuticals has actually shown its own hand in advance of a possible face-off with Io...

Pfizer, Valneva reveal lyme disease chance reliable for second booster

.Pfizer and also Valneva might possess about pair of additional years to stand by before they help m...

Fierce Biotech Managing Editor Ayla Ellison Speaks Shop with Michelle Benz on the Future of Biotech.

.Let's study a conversation along with Ayla Ellison, Ferocious Biotech Editor-in-Chief as well as Mi...

New records show how Bayer's asundexian neglected to avoid strokes

.Bayer put on hold the period 3 trial for its variable XIa inhibitor asundexian behind time in 2015 ...

Sanofi's tolebrutinib neglects 2 of 3 late-stage MS tests

.Sanofi is still set on taking its several sclerosis (MS) med tolebrutinib to the FDA, managers have...

Galapagos' stock up as fund shows intent to mold its progression

.Galapagos is coming under extra pressure from investors. Having constructed a 9.9% concern in Galap...

Cell- centered Sana gathers initial CSO-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of substantial leadership hirings, shootings...